<DOC>
	<DOC>NCT01421303</DOC>
	<brief_summary>Patients with Ankylosing spondylitis more frequently discontinue work. This study measures the impact of Enbrel on work participation.</brief_summary>
	<brief_title>Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.</brief_title>
	<detailed_description>Purely descriptive</detailed_description>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis, Ankylosing</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Active AS patients (as judged by the treating MD) who are currently employed. Patients who are scheduled by their rheumatologist to initiate treatment with Etanercept. Patients who initiated a procedure for eligibility of work disability/pension. Patients with previous use of TNFalpha inhibitors either in commercial use, or in a study for the treatment of AS or a related spondylarthropathy condition.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>